Nektar Therapeutics (Movantik, Adynovate, Rebinyn)

Business Data, Corporate Office and Headquarter Address

About

Nektar Therapeutics (Movantik, Adynovate, Rebinyn) is Buildings and Property in United States that focus on a portfolio business. They cover business area such as a portfolio, royalty, future sale, approve drug, right, pharmaceutical drug, Movantik, Adynovate, Rebinyn.

Business Type

Buildings and Property

Country

United States

Founded

-

Company Focus

A Portfolio

Website

-

Corporate Office and Headquarter Office address:

San Francisco, CA
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

a portfolioroyaltyfuture saleapprove drugrightpharmaceutical drugMovantikAdynovateRebinyn

* We use standard office opening hours in near Nektar Therapeutics (Movantik, Adynovate, Rebinyn)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Nektar Therapeutics (Movantik, Adynovate, Rebinyn) Frequently Asked Questions

What or who is Nektar Therapeutics (Movantik, Adynovate, Rebinyn)?

Nektar Therapeutics (Movantik, Adynovate, Rebinyn) is Buildings and Property business from United States that founded in - ( years old in ), Nektar Therapeutics (Movantik, Adynovate, Rebinyn) business is focusing on A Portfolio.

Where is Nektar Therapeutics (Movantik, Adynovate, Rebinyn) headquarter and corporate office address?

Nektar Therapeutics (Movantik, Adynovate, Rebinyn) headquarter office and corporate office address is located in San Francisco, CA United States.

Where is Nektar Therapeutics (Movantik, Adynovate, Rebinyn) country origins?

Nektar Therapeutics (Movantik, Adynovate, Rebinyn) was founded in United States.

What is A Portfolio business focus on?

In , Nektar Therapeutics (Movantik, Adynovate, Rebinyn) is currently focus on a portfolio sector.

Disclaimer: This website is not affiliated with Nektar Therapeutics (Movantik, Adynovate, Rebinyn), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.